Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



ACS: Colorectal cancer screening 'should start at age 45'

The average American should start regular colorectal cancer screenings at the age of 45, according to new guidelines issued by the American Cancer Society (ACS). Previous recommendations from the organization suggested people at average risk of the condition should begin a screening schedule at the...

Read More

CDC warns about infection risk in hotel pools and hot tubs

One in three waterborne disease outbreaks in the United States between 2000 and 2014 occurred in hotel pools and hot tubs, according to recent findings published by the Centers for Disease Control and Prevention (CDC). The  Morbidity and Mortality Weekly Report found more than half the...

Read More

Trump unveils blueprint for lowering prescription drug prices

President Donald Trump has unveiled a “blueprint” to lower the price of prescription drugs in the United States. The plans include building on the existing administrative efforts of the US Food and Drug Administration (FDA) to increase generic drug approvals, reforms to the Medicare...

Read More

Tagrisso approved as first-line treatment for metastatic NSCLC

The US Food and Drug Administration (FDA) has approved the protein kinase inhibitor Tagrisso (osimertinib) as a first-line treatment option for certain patients with metastatic non-small cell lung carcinoma (NSCLC). Earlier this month, AstraZeneca presented new data from a Phase III FLAURA trial...

Read More

Sale of Essure contraceptive device restricted by FDA

The US Food and Drug Administration (FDA) has taken steps to restrict the sale and distribution of the Essure device, citing the lack of awareness of the risks and benefits among many women opting for this form of contraception as one of its main concerns. “Based on our review of a growing...

Read More

FDA okays first drug therapy for rare inherited form of rickets

The US Food and Drug Administration (FDA) has approved Crysvita (burosumab) as a treatment for a rare form of inherited rickets. It is the first drug therapy approved as a treatment for x-linked hypophosphatemia (XLH) with evidence of bone disease in children over one year of age and adolescents...

Read More